Joel Dapello

Joel Dapello is an engineer and scientist who has worked at the intersection of Bio, Neuro, and AI for over ten years, developing methods to accelerate biological sciences.

Joel was the founding engineer at BioBright (acquired by Dotmatics), working with Charles Fracchia and Adam Marblestone to develop the first end-to-end encrypted data collection and analysis platform for life sciences. He completed his PhD in Applied Mathematics at Harvard University working with Jim DiCarlo and David Cox studying real and artificial neural representations and developing brain-inspired methods to improve adversarial robustness in deep learning models.

Currently, Joel is a machine learning scientist at Altos Labs, where he founded and developed the multimodality foundation models program and now leads a cross-functional team developing agentic AI platforms for therapeutic target assessment and prioritization.